Trial Profile
A phase II study of Gleevec [imatinib], idarubicin and cytarabine in patients with chronic myeloid leukemia in blast phase
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2005
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Cytarabine; Idarubicin
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 08 Dec 2005 New trial record.